Document Preview Unavailable
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia
Pastoors, Dorien; Havermans, Marije; Mulet-Lazaro, Roger; Smeenk, Leonie; Ottema, Sophie; et al. bioRxiv, Jan 2, 2025.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




